Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza

P. Koul (Srinagar (Jammu and Kashmir), India), H. Mir (Srinagar (Jammu and Kashmir), India), T. Shah (Srinagar (Jammu and Kashmir), India)

Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Session: Respiratory viruses in the "pre COVID-19" era
Session type: E-poster session
Number: 2386
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Koul (Srinagar (Jammu and Kashmir), India), H. Mir (Srinagar (Jammu and Kashmir), India), T. Shah (Srinagar (Jammu and Kashmir), India). Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza. 2386

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Limited effect of clarithromycin in non-elderly, non-severe patients with influenza
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012


Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir
Source: Eur Respir J 2014; 44: 535-537
Year: 2014


Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020
Year: 2021



Efficacy of the neuraminidase inhibitors in treating influenza pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004

Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients
Source: Eur Respir J 2015; 45: 1642-1652
Year: 2015



Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Combination therapy (beta-lactam+macrolide) vs fluoroquinolone monotherapy for the treatment of CAP
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012


Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010


Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP)
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008


Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Combination versus monotherapy for nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 50-55
Year: 2007



Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
Source: Eur Respir J, 53 (3) 1802396; 10.1183/13993003.02396-2018
Year: 2019



A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
Source: Eur Respir J, 55 (1) 1901181; 10.1183/13993003.01181-2019
Year: 2020



Efficacy of corticosteroids in hospital treated community-acquired pneumonia
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012

Duration of therapy in hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007